Trademark: 88933620
Status Date
Tuesday, March 2, 2021
Registration Number
6280633
Registration Date
Tuesday, March 2, 2021
Filing Date
Tuesday, May 26, 2020
Published for Opposition
Tuesday, December 15, 2020
42 Pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without mRNA engineering; pharmaceutical research and development services, in the field of gene-editing, mRNA engineering, cell reprogramming, and cell therapy development
The wording "ERIGEN" has no meaning in a foreign language.
Mar 2, 2021
Registered-Principal Register
Dec 15, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2020
Published For Opposition
Nov 25, 2020
Notification Of Notice Of Publication E-Mailed
Nov 12, 2020
Approved For Pub - Principal Register
Nov 12, 2020
Examiner's Amendment Entered
Nov 12, 2020
Notification Of Examiners Amendment E-Mailed
Nov 12, 2020
Examiners Amendment E-Mailed
Nov 12, 2020
Examiners Amendment -Written
Aug 28, 2020
Notification Of Non-Final Action E-Mailed
Aug 28, 2020
Non-Final Action E-Mailed
Aug 28, 2020
Non-Final Action Written
Aug 26, 2020
Assigned To Examiner
Jun 12, 2020
New Application Office Supplied Data Entered In Tram
May 29, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
